A PROTAC Augmenter for Photo‐Driven Pyroptosis in Breast Cancer
Authors:
- 22 February 2024
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 36 (21) , e2313460
Abstract
Proteolysis targeting chimera (PROTAC) has recently emerged as a promising strategy for inducing post‐translational knockdown of target proteins in disease treatment. The degradation of bromodomain‐containing protein 4 (BRD4), an essential nuclear protein for gene transcription, induced by PROTAC is proposed as an epigenetic approach to treat breast cancer. However, the poor membrane permeability and indiscriminate distribution of PROTAC in vivo results in low bioavailability, limiting its development and application. Herein, a nano “targeting chimera” (abbreviated as L@NBMZ) consisting of BRD4‐PROTAC combined with a photosensitizer, to serve as the first augmenter for photo‐driven pyroptosis in breast cancer, is developed. With excellent BRD4 degradation ability, high biosafety, and biocompatibility, L@NBMZ blocks gene transcription by degrading BRD4 through proteasomes in vivo, and surprisingly, induces the cleavage of caspase‐3. This type of caspase‐3 cleavage is synergistically amplified by light irradiation in the presence of photosensitizers, leading to efficient photo‐driven pyroptosis. Both in vitro and in vivo outcomes demonstrate the remarkable anti‐cancer efficacy of this augmenter, which significantly inhibits the lung metastasis of breast cancer in vivo. Thus, the photo‐PROTAC “targeting chimera” augmenter construction strategy may pave a new way for expanding PROTAC applications within anti‐cancer paradigms.Keywords
Funding Information
- National Natural Science Foundation of China (22090011)
- Fundamental Research Funds for the Central Universities (DUT22LAB608)
This publication has 56 references indexed in Scilit:
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancerProceedings of the National Academy of Sciences, 2016
- Small‐Molecule PROTACS: New Approaches to Protein DegradationAngewandte Chemie International Edition, 2016
- Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific TargetingMolecular Cell, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Selective inhibition of BET bromodomainsNature, 2010
- RNAi in Budding YeastScience, 2009
- Lead- and drug-like compounds: the rule-of-five revolutionDrug Discovery Today: Technologies, 2004
- Exploiting tumour hypoxia in cancer treatmentNature Reviews Cancer, 2004
- Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradationProceedings of the National Academy of Sciences, 2001